Parenteral Drugs India
PDPL · Pharma > Pharmaceuticals & Drugs · Chairman: Manohar Lal Gupta · MD: Vinod Kumar Gupta · Listing date: Aug. 19, 2010 · Employees: 909 · Indore · http://www.pdindia.com

Stock Price vs Company Growth
1d
0.0%
1w
0.0%
1m
0.0%
3m
4.6%
6m
0.0%
1y
0.0%
5y
5.9%
10y
18.3%
all
24.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 3.39 0%
N/A
3.39
Company Overview

Sales
8.54 Cr
Growth: -1.8%
Profit after Tax
-129 Cr
Growth: 2.8%
Micro Cap
10.1 Cr
P/S: 1.2x
Industry P/S: 3.1x
Fundamentals

Sales (Cr) ₹ 8.54
Growth -1.8%
EBITDA -182.8%
P/S 1.2x
Dividend 0.0%
P/E -0.1x
Book Value ₹ -237
PEG Ratio 0.1x
ROE 19.5%
P/B N/A
Shareholding Pattern

Institutions
Promoters
M V G Mercantile Private Limited
32.61 %
Rajratan Exports Private Limited
22.36 %
Pdpl Holdings Private Limited
10.79 %
Mahaganpati Investment Private Limited
5.37 %
Pdpl Securities Private Limited
2.05 %
Others
Shitiz Sehgal
1.4 %
Amax Network Pvt Ltd
1.34 %
Iepf
0.3 %
Increase    Decrease    No change
Company Profile Detailed

Established in the year 1983, Parenteral Drugs has dedicated itself to the manufacturing of the best quality vital life saving drug at the lowest possible cost. Over the years, its path breaking innovation has led not only to lower costs but better quality as well because PDPL firmly believes that better quality dose not necessarily mean higher price, it can also be achieved by indigenous techniques and innovative technologies.Commencing with production of I.V.
Investors (29)